Learn About Microscopic Polyangiitis

What is the definition of Microscopic Polyangiitis?
Microscopic polyangiitis (MPA) is a disorder that causes blood vessel inflammation (vasculitis), which can lead to organ damage. The kidneys, lungs, nerves, skin, and joints are the most commonly affected areas of the body. MPA is diagnosed in people of all ages, all ethnicities, and both genders. The cause of this disorder is unknown.
Save information for later
Sign Up
What are the alternative names for Microscopic Polyangiitis?
  • Microscopic polyangiitis
Who are the top Microscopic Polyangiitis Local Doctors?
PM
Dr. Peter A. Merkel
Rheumatology
Elite
Highly rated in
22
conditions
Rheumatology

Penn Medicine

Perelman Center For Advanced Medicine

3400 Civic Center Blvd, 
Philadelphia, PA 

Peter Merkel is a Rheumatologist in Philadelphia, Pennsylvania. Merkel has been practicing medicine for over 34 years and is rated as an Elite expert by MediFind in the treatment of Microscopic Polyangiitis. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, and Takayasu Arteritis. He is licensed to treat patients in Pennsylvania and Massachusetts. Merkel is currently accepting new patients.

CP
Christian Pagnoux
Elite
Highly rated in
22
conditions

Canadian Rheumatology Association

Mount Sinai Hospital, Toronto, 
Toronto, ON, CA 

Christian Pagnoux practices in Toronto, Canada. Pagnoux is rated as an Elite expert by MediFind in the treatment of Microscopic Polyangiitis. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Polyarteritis Nodosa, and Microscopic Polyangiitis.

 
 
 
 
Learn about our expert tiers
Learn more
AS
Dr. Antoine G. Sreih
Rheumatology
Elite
Highly rated in
15
conditions
Rheumatology

Penn Medicine

Perelman Center For Advanced Medicine

3400 Civic Center Blvd, 
Philadelphia, PA 

Antoine Sreih is a Rheumatologist in Philadelphia, Pennsylvania. Sreih has been practicing medicine for over 27 years and is rated as an Elite expert by MediFind in the treatment of Microscopic Polyangiitis. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Vasculitis, and Takayasu Arteritis. He is licensed to treat patients in Pennsylvania. Sreih is currently accepting new patients.

View All Doctors
What are the latest Microscopic Polyangiitis Clinical Trials?
Hydroxychloroquine in ANCA Vasculitis Evaluation - A Multicentre, Randomised, Double-blind, Placebo-controlled Trial
Who is this study for: Patients with Anti-Neutrophilic Cytoplasmic Autoantibodies Vasculitis
Enrollment Status: Recruiting
Publish Date: March 18, 2022
Intervention Type: Drug
Study Drugs: Hydroxychloroquine
Study Phase: Phase 4
Summary: The purpose of this study is to find out whether hydroxychloroquine, in addition to background treatments, reduces disease activity in patients with Anti-Neutrophilic Cytoplasmic Autoantibodies (ANCA) Vasculitis, a group of autoimmune diseases.~Hydroxychloroquine and is an established, effective, safe and inexpensive therapy, widely used in other autoimmune diseases such as lupus and rheumatoid ar...
Match to trials
Find the right clinical trials for you in under a minute
Get started
VCRC Genetic Repository One-Time DNA Protocol
Enrollment Status: Recruiting
Publish Date: May 17, 2022
Summary: The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researc...
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Microscopic Polyangiitis?
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Condition: Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Journal: JAMA network open
Treatment Used: Rituximab
Number of Patients: 93
Published: July 08, 2022
Summary: Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis.
Condition: Diffuse Alveolar Hemorrhage with Microscopic Polyangiitis
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Treatment Used: Plasma Exchange Therapy
Number of Patients: 20
Published: March 05, 2022
Summary: Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis.
Tired of the same old research?
Check Latest Advances
Obinutuzumab as treatment for ANCA-associated vasculitis.
Condition: ANCA-Associated Vasculitis
Journal: Rheumatology (Oxford, England)
Treatment Used: Obinutuzumab
Number of Patients: 3
Published: December 27, 2021
Summary: Obinutuzumab as treatment for ANCA-associated vasculitis.
View All Latest Advances